Neutrophil to lymphocyte ratio as a marker of diabetic nephropathy

IF 0.2 Q4 Biochemistry, Genetics and Molecular Biology
Hemang ., A. Chauhan, S. Gaur, S. Pal, P. Chanalia
{"title":"Neutrophil to lymphocyte ratio as a marker of diabetic nephropathy","authors":"Hemang ., A. Chauhan, S. Gaur, S. Pal, P. Chanalia","doi":"10.25303/1811rjbt065069","DOIUrl":null,"url":null,"abstract":"Aim of the study is to estimate and analyze neutrophil to lymphocyte ratio (NLR) in diabetes mellitus as a marker of diabetic nephropathy (DN). Forty individuals with DN and forty patients with diabetes mellitus without nephropathy were enrolled. Inclusion criteria included patients with diabetic nephropathy (albuminuria >30 mg/day and/or eGFR <60 mL/min/1.73 m2) in the absence of additional kidney damage symptoms. Complete blood count, glycated haemoglobin (HbA1c), 24-hour urine albumin and serum creatinine were evaluated and compared. The mean NLR of the patients with DN (Cases) was 3.09 ± 0.88 (1.34-4.91) and in patients with diabetes mellitus only (Controls) it was 2.17 ± 0.69 (0.89-3.98). The correlation between urinary albumin excretion (p value =0.0004) and estimated glomerular filtration rate (p value =0.0002) also came out positive and negative respectively. Based on unpaired t-test, the difference between NLR values among the group came out statistically highly significant (p < 0.05). Thus, the NLR in both groups was not comparable. NLR was substantially higher in diabetic nephropathy patients compared to diabetes mellitus patients. Thus, NLR provides us with a simple and low-cost assessment that may be employed as a predictive instrument to diagnose diabetic nephropathy at a preliminary phase.","PeriodicalId":21091,"journal":{"name":"Research Journal of Biotechnology","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25303/1811rjbt065069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Aim of the study is to estimate and analyze neutrophil to lymphocyte ratio (NLR) in diabetes mellitus as a marker of diabetic nephropathy (DN). Forty individuals with DN and forty patients with diabetes mellitus without nephropathy were enrolled. Inclusion criteria included patients with diabetic nephropathy (albuminuria >30 mg/day and/or eGFR <60 mL/min/1.73 m2) in the absence of additional kidney damage symptoms. Complete blood count, glycated haemoglobin (HbA1c), 24-hour urine albumin and serum creatinine were evaluated and compared. The mean NLR of the patients with DN (Cases) was 3.09 ± 0.88 (1.34-4.91) and in patients with diabetes mellitus only (Controls) it was 2.17 ± 0.69 (0.89-3.98). The correlation between urinary albumin excretion (p value =0.0004) and estimated glomerular filtration rate (p value =0.0002) also came out positive and negative respectively. Based on unpaired t-test, the difference between NLR values among the group came out statistically highly significant (p < 0.05). Thus, the NLR in both groups was not comparable. NLR was substantially higher in diabetic nephropathy patients compared to diabetes mellitus patients. Thus, NLR provides us with a simple and low-cost assessment that may be employed as a predictive instrument to diagnose diabetic nephropathy at a preliminary phase.
中性粒细胞与淋巴细胞比值作为糖尿病肾病的标志
研究的目的是估计和分析糖尿病中性粒细胞与淋巴细胞比值(NLR)作为糖尿病肾病(DN)的标志。纳入40例DN患者和40例无肾病的糖尿病患者。纳入标准包括糖尿病肾病患者(蛋白尿30mg /天和/或eGFR 60ml /min/1.73 m2),且无其他肾损害症状。评估并比较全血细胞计数、糖化血红蛋白(HbA1c)、24小时尿白蛋白和血清肌酐。DN患者(病例)的NLR平均值为3.09±0.88(1.34-4.91),单纯糖尿病患者(对照组)的NLR平均值为2.17±0.69(0.89-3.98)。尿白蛋白排泄量(p值=0.0004)与肾小球滤过率估计值(p值=0.0002)也分别呈正相关和负相关。经非配对t检验,两组NLR值差异有显著统计学意义(p <0.05)。因此,两组NLR不具有可比性。糖尿病肾病患者的NLR明显高于糖尿病患者。因此,NLR为我们提供了一种简单、低成本的评估方法,可作为早期诊断糖尿病肾病的预测工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Research Journal of Biotechnology
Research Journal of Biotechnology 工程技术-生物工程与应用微生物
CiteScore
0.60
自引率
0.00%
发文量
192
审稿时长
1.5 months
期刊介绍: We invite you to contribute Research Papers / Short Communications / Review Papers: -In any field of Biotechnology, Biochemistry, Microbiology and Industrial Microbiology, Soil Technology, Agriculture Biotechnology. -in any field related to Food Biotechnology, Nutrition Biotechnology, Genetic Engineering and Commercial Biotechnology. -in any field of Biotechnology related to Drugs and Pharmaceutical products for human beings, animals and plants. -in any field related to Environmental Biotechnolgy, Waste Treatment of Liquids, Soilds and Gases; Sustainability. -in inter-realted field of Chemical Sciences, Biological Sciences, Environmental Sciences and Life Sciences. -in any field related to Biotechnological Engineering, Industrial Biotechnology and Instrumentation. -in any field related to Nano-technology. -in any field related to Plant Biotechnology.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信